Novartis Pharma vs. Medac Farma, Court of Milan, 10 January 2022, Case number 11933/2022

A decision on second medical use patent and skinny labelling in Italy was handed down by the Court of Milan on 10 January 2022. The Court held skinny label alone as insufficient to avoid infringement of second medical use claims and imposed various obligations on the generic company in order to lawfully market its drug.

The judgment (in Italian) can be read here.
The entire summary can be read here.

Headnote and summary: Luca Giove and Giorgia Zecchin, GR Legal